Your browser doesn't support javascript.
loading
Assessing the impact and safety of implantable cardioverter defibrillators in treating catecholaminergic polymorphic ventricular tachycardia: a systematic review and meta-analysis protoc.
Dong, Zhenyu; Shang, Shuai; Mu, Yali; Yusup, Rukiya; Li, Yaodong; Zhou, Xianhui; Lu, Yanmei; Tang, Baopeng.
Afiliación
  • Dong Z; Department of Pacing and Electrophysiology&Department of Cardiac Electrophysiology and Remodeling, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China.
  • Shang S; Department of Pacing and Electrophysiology&Department of Cardiac Electrophysiology and Remodeling, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China.
  • Mu Y; Department of Pacing and Electrophysiology&Department of Cardiac Electrophysiology and Remodeling, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China.
  • Yusup R; Department of Pacing and Electrophysiology&Department of Cardiac Electrophysiology and Remodeling, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China.
  • Li Y; Department of Pacing and Electrophysiology&Department of Cardiac Electrophysiology and Remodeling, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China.
  • Zhou X; Department of Pacing and Electrophysiology&Department of Cardiac Electrophysiology and Remodeling, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China.
  • Lu Y; Department of Pacing and Electrophysiology&Department of Cardiac Electrophysiology and Remodeling, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China tangbaopeng1111@163.com gracy@189.cn.
  • Tang B; Department of Pacing and Electrophysiology&Department of Cardiac Electrophysiology and Remodeling, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China tangbaopeng1111@163.com gracy@189.cn.
BMJ Open ; 14(8): e078165, 2024 Aug 13.
Article en En | MEDLINE | ID: mdl-39142670
ABSTRACT

BACKGROUND:

While the guidelines acknowledge the anticipated benefits of using an implantable cardioverter defibrillator (ICD) in individuals with catecholaminergic polymorphic ventricular tachycardia (CPVT). However, the potential adverse effects have received less attention. METHODS AND

ANALYSIS:

To address this issue comprehensively, we will explore various databases such as the Cochrane Library, Web of Science, EMBASE and PubMed. Our study will include CPVT patients, both with and without ICD implantation. Two researchers will evaluate the eligible studies independently and gather pertinent data. The quality of the studies included will be assessed using either the Newcastle-Ottawa Scale or the Cochrane Risk of Bias Tool. Data analysis will be conducted using RevMan. ETHICS AND DISSEMINATION Because this research depends exclusively on existing studies, obtaining patient informed consent and ethics approval is unnecessary. The results of this meta-analysis will be shared at conferences or in peer-reviewed journals. PROSPERO REGISTRATION NUMBER CRD42022370824.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taquicardia Ventricular / Desfibriladores Implantables Límite: Humans Idioma: En Revista: BMJ Open Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taquicardia Ventricular / Desfibriladores Implantables Límite: Humans Idioma: En Revista: BMJ Open Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido